Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chin B Eap

Showing results (1-10 of 179) with videos related to

Pageof 18
Sort By:
Dialogues in Clinical Neuroscience|October 21, 2016
Personalized prescribing: a new medical model for clinical implementation of psychotropic drugsChin B Eap
International Clinical Psychopharmacology|January 20, 2006
Aripiprazole and suicidalityLaurent Holzer, Chin B Eap
Human Psychopharmacology|October 31, 2002
Enantiomeric antidepressant drugs should be considered on individual meritPierre Baumann, Chin B. Eap
Journal of Clinical Psychopharmacology|April 25, 2006
Risperidone-induced symptomatic hyperprolactinaemia in adolescentsLaurent Holzer, Chin B Eap
Clinical Pharmacokinetics|February 15, 2013
Pharmacodynamic, pharmacokinetic and pharmacogenetic aspects of drugs used in the treatment of Alzheimer's diseaseMuriel Noetzli, Chin B Eap
Pharmacological Research|October 23, 2008
Citalopram enantiomers in plasma and cerebrospinal fluid of ABCB1 genotyped depressive patients and clinical response: a pilot studyGeorg Nikisch, Chin B Eap, Pierre Baumann
Current Hypertension Reports|August 6, 2014
Blood pressure in relation to coffee and caffeine consumptionIdris Guessous, Chin B Eap, Murielle Bochud
Critical Care (London, England)|March 7, 2007
Could pharmacogenetic data explain part of the interindividual sensitivity to methadone-induced respiratory depression?Séverine Crettol, Martine Monnat, Chin B Eap
Clinical Pharmacokinetics|October 31, 2002
Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependenceChin B Eap, Thierry Buclin, Pierre Baumann
Pharmacogenetics and Genomics|March 16, 2013
Pharmacogenetics of CYP1A2 activity and inducibility in smokers and exsmokersMaria Dobrinas, Jacques Cornuz, Chin B Eap
Pageof 18

Showing results (1-10 of 179) with videos related to

Sort By:
Pageof 18
Dialogues in Clinical Neuroscience|October 21, 2016
Personalized prescribing: a new medical model for clinical implementation of psychotropic drugsChin B Eap
International Clinical Psychopharmacology|January 20, 2006
Aripiprazole and suicidalityLaurent Holzer, Chin B Eap
Human Psychopharmacology|October 31, 2002
Enantiomeric antidepressant drugs should be considered on individual meritPierre Baumann, Chin B. Eap
Journal of Clinical Psychopharmacology|April 25, 2006
Risperidone-induced symptomatic hyperprolactinaemia in adolescentsLaurent Holzer, Chin B Eap
Clinical Pharmacokinetics|February 15, 2013
Pharmacodynamic, pharmacokinetic and pharmacogenetic aspects of drugs used in the treatment of Alzheimer's diseaseMuriel Noetzli, Chin B Eap
Pharmacological Research|October 23, 2008
Citalopram enantiomers in plasma and cerebrospinal fluid of ABCB1 genotyped depressive patients and clinical response: a pilot studyGeorg Nikisch, Chin B Eap, Pierre Baumann
Current Hypertension Reports|August 6, 2014
Blood pressure in relation to coffee and caffeine consumptionIdris Guessous, Chin B Eap, Murielle Bochud
Critical Care (London, England)|March 7, 2007
Could pharmacogenetic data explain part of the interindividual sensitivity to methadone-induced respiratory depression?Séverine Crettol, Martine Monnat, Chin B Eap
Clinical Pharmacokinetics|October 31, 2002
Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependenceChin B Eap, Thierry Buclin, Pierre Baumann
Pharmacogenetics and Genomics|March 16, 2013
Pharmacogenetics of CYP1A2 activity and inducibility in smokers and exsmokersMaria Dobrinas, Jacques Cornuz, Chin B Eap
Pageof 18